1. Home
  2. DPRO vs ALEC Comparison

DPRO vs ALEC Comparison

Compare DPRO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$6.64

Market Cap

230.7M

Sector

Industrials

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$2.05

Market Cap

262.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPRO
ALEC
Founded
1998
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
262.7M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
DPRO
ALEC
Price
$6.64
$2.05
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$15.67
$4.83
AVG Volume (30 Days)
1.9M
758.9K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$21,045,000.00
Revenue This Year
$42.16
N/A
Revenue Next Year
$145.52
$45.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$0.87
52 Week High
$14.37
$3.40

Technical Indicators

Market Signals
Indicator
DPRO
ALEC
Relative Strength Index (RSI) 46.34 45.57
Support Level $6.23 $1.82
Resistance Level $7.15 $2.02
Average True Range (ATR) 0.50 0.17
MACD 0.03 -0.02
Stochastic Oscillator 40.92 19.12

Price Performance

Historical Comparison
DPRO
ALEC

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: